Liver transplantation in two children with tyrosinaemia type I: biochemical aspects.

Suppr

超能文献

作者信息

Riudor E, Ribes A, Lloret J, Friden J, Holme E, Jakobs C, Martinez Ibanez V

机构信息

Hospital Materno Infantil, Ciutat Sanitaria Vall d'Hebron, Barcelona, Spain.

出版信息

J Inherit Metab Dis. 1991;14(3):281-4. doi: 10.1007/BF01811682.

DOI:10.1007/BF01811682

PMID:1770775

Abstract

摘要

相似文献

Liver transplantation in two children with tyrosinaemia type I: biochemical aspects.

J Inherit Metab Dis. 1991;14(3):281-4. doi: 10.1007/BF01811682.

Liver transplantation in tyrosinaemia type I: the Groningen experience.

J Inherit Metab Dis. 1995;18(2):115-8. doi: 10.1007/BF00711743.

Liver transplantation in nine Spanish patients with tyrosinaemia type I.

J Inherit Metab Dis. 1995;18(2):119-22. doi: 10.1007/BF00711744.

[Tyrosinemia].

Duodecim. 1992;108(9):841-3.

Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem.

J Inherit Metab Dis. 1989;12 Suppl 2:339-42. doi: 10.1007/BF03335416.

Liver transplantation in tyrosinaemia type 1: the dilemma of timing the operation.

Acta Paediatr. 1992 May;81(5):449-52. doi: 10.1111/j.1651-2227.1992.tb12270.x.

Hematin therapy for the neurologic crisis of tyrosinemia.

J Pediatr. 1991 Jan;118(1):136-9. doi: 10.1016/s0022-3476(05)81867-0.

Screening for tyrosinaemia type I.

Arch Dis Child Fetal Neonatal Ed. 1996 May;74(3):F191-4. doi: 10.1136/fn.74.3.f191.

[Renal involvement in type I tyrosinemia].

Arch Pediatr. 1994 Apr;1(4):417-8.

Richner-Hanhart syndrome (oculocutaneous tyrosinaemia, tyrosinaemia type II).

J R Soc Med. 1992 Dec;85(12):759-60. doi: 10.1177/014107689208501216.

引用本文的文献

Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1.

Paediatr Drugs. 2019 Dec;21(6):413-426. doi: 10.1007/s40272-019-00364-4.

Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.

J Inherit Metab Dis. 1998 Aug;21(5):518-31. doi: 10.1023/a:1005462804271.

本文引用的文献

Inhibition of delta-aminolevulinic acid dehydrase by 4,6-dioxoheptanoic acid.

J Biol Chem. 1981 Oct 10;256(19):9915-23.

Determination of urinary succinylacetone by capillary gas chromatography.

J Chromatogr Sci. 1984 May;22(5):211-5. doi: 10.1093/chromsci/22.5.211.

The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase.

Scand J Clin Lab Invest Suppl. 1986;184:35-40.

Stable isotope dilution analysis of succinylacetone using electron capture negative ion mass fragmentography: an accurate approach to the pre- and neonatal diagnosis of hereditary tyrosinemia type I.

Clin Chim Acta. 1988 Feb 15;171(2-3):223-31. doi: 10.1016/0009-8981(88)90147-7.

Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma.

J Pediatr. 1985 Apr;106(4):604-6. doi: 10.1016/s0022-3476(85)80081-0.

Possibilities for treatment and for early prenatal diagnosis of hereditary tyrosinaemia.

Lancet. 1985 Mar 2;1(8427):527. doi: 10.1016/s0140-6736(85)92132-4.

Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma.

Hepatology. 1990 Mar;11(3):481-8. doi: 10.1002/hep.1840110321.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验